Timing of blood sample collection in combined first‐trimester screening for chromosomal aberrations and pre‐eclampsia screening

Documenti analoghi

• Atypicality index as an add‐on to combined first‐trimester screening for chromosomal aberrations
  di: K. Gadsbøll, et al.
  Pubblicazione: (2024)
• Predictive performance of Fetal Medicine Foundation first‐trimester screening algorithm for pre‐eclampsia according to conception mode
  di: A. S. L. Kjaer, et al.
  Pubblicazione: (2026)
• OC17.02: Adherence to guideline‐recommended aspirin for pre‐eclampsia prevention in Denmark
  di: I. Riishede, et al.
  Pubblicazione: (2024)
• Screening for pre‐eclampsia with competing‐risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestation
  di: I. Riishede, et al.
  Pubblicazione: (2024)
• Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT
  di: K. Gadsbøll, et al.
  Pubblicazione: (2024)